Catalyst Wire Dossier Catalyst Wire Dossier

Boswellia-based intracanal medication

Boswellia serrata resin extract-based intracanal medicament · Mansoura University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Boswellia-based intracanal medication, covering 2024-06-20 to 2024-06-20. Get the full timeline:

Most recent: Clinical Trial Update: Investigate"Clinically" the Effectiveness of Boswellia Based Intracanal Medication Compared to Calcium Hydroxide Ca(OH)2 and Ledermix on the Levels of Bacteria and Inflammatory Cytokines in Root Canals and Periradicular Tissues of Teeth With Apical Periodontitis [Phase 2, Phase 3]

See pricing